Cyclopharm Limited (ASX:CYC)
Australia · Delayed Price · Currency is AUD 0.4800
0.00 (0.00%)
Sep 22, 2026, 4:10 PM AEST
Cyclopharm Market Cap
Cyclopharm has a market cap or net worth of 60.35 million as of September 22, 2026. Its market cap has decreased by -38.29% in one year.
Market Cap
60.35M
Enterprise Value
55.91M
Revenue
34.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.48
ChartMarket Cap Chart
Since January 18, 2007, Cyclopharm's market cap has increased from 50.89M to 60.35M, an increase of 18.59%. That is a compound annual growth rate of 0.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 60.35M | -44.59% |
| Dec 30, 2025 | 108.91M | -38.17% |
| Dec 31, 2024 | 176.15M | -2.75% |
| Dec 29, 2023 | 181.14M | 66.37% |
| Dec 30, 2022 | 108.87M | -28.90% |
| Dec 30, 2021 | 153.13M | -23.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 103.93M |
| Saluda Medical | 100.81M |
| SomnoMed | 72.52M |
| Epiminder | 60.67M |
| Compumedics | 49.94M |
| HeraMED | 47.50M |
| Cleo Diagnostics | 45.25M |
| Nova Eye Medical | 38.46M |